Patent Assignment
Reel/Frame 054402/0144
Assignment of Assignor's Interest
Recorded: 2020-11-18
Pages: 4
Assignee
MYELOID THERAPEUTICS, INC.
800 BOYLSTON STREET, SUITE 2222, BOSTON, MASSACHUSETTS, 02199
Covered Properties
(3)
Engineered Phagocytic Receptor Compositions and Methods of Use Thereof
Engineered Phagocytic Receptor Compositions and Methods of Use Thereof
Engineered Chimeric Fusion Protein Compositions and Methods of Use Thereof
PCT:
PCT/US2020/030837 ↗
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 22, 2020
From: GETTS, DANIEL; WANG, YUXIAO
To: MYELOID THERAPEUTICS, INC.
Reel/Frame 052459/0765 →
Assignment of Assignor's Interest
May 26, 2020
From: GETTS, DANIEL; WANG, YUXIAO
To: MYELOID THERAPEUTICS, INC.
Reel/Frame 052752/0054 →
Assignment of Assignor's Interest
Nov 18, 2020
From: GETTS, DANIEL; WANG, YUXIAO
To: MYELOID THERAPEUTICS, INC.
Reel/Frame 054402/0225 →
Change of Name
Apr 13, 2026
From: MYELOID THERAPEUTICS, INC.
To: CREATE MEDICINES, INC.
Reel/Frame 075384/0783 →